Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kari Lancaster

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
The International Journal on Drug Policy|February 5, 2014
Social construction and the evidence-based drug policy endeavourKari Lancaster
Addiction (Abingdon, England)|September 2, 2016
Rethinking recoveryKari Lancaster
The International Journal on Drug Policy|April 5, 2020
How to think with models and targets: Hepatitis C elimination as a numbering performanceTim Rhodes, Kari Lancaster
The International Journal on Drug Policy|August 13, 2013
Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985-2010Kari Lancaster, Alison Ritter
The International Journal on Drug Policy|July 17, 2019
Evidence-making hepatitis C cure: Towards a science that knows more carefullyTim Rhodes, Kari Lancaster
Social Science & Medicine (1982)|August 19, 2019
Evidence-making interventions in health: A conceptual framingTim Rhodes, Kari Lancaster
Sociology of Health & Illness|May 4, 2021
Excitable models: Projections, targets, and the making of futures without diseaseTim Rhodes, Kari Lancaster
The International Journal on Drug Policy|September 11, 2020
Towards an ontological politics of drug policy: Intervening through policy, evidence and methodKari Lancaster, Tim Rhodes
The International Journal on Drug Policy|May 22, 2016
Corrigendum to "Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985-2010" [Int. J. Drug Policy 25 (2014) 81-87]Kari Lancaster, Alison Ritter
Addiction (Abingdon, England)|March 13, 2018
Commentary on Chang et al. (2018): Assessing prescribing volume and patient risk-implementation considerationsSuzanne Nielsen, Kari Lancaster
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
The International Journal on Drug Policy|February 5, 2014
Social construction and the evidence-based drug policy endeavourKari Lancaster
Addiction (Abingdon, England)|September 2, 2016
Rethinking recoveryKari Lancaster
The International Journal on Drug Policy|April 5, 2020
How to think with models and targets: Hepatitis C elimination as a numbering performanceTim Rhodes, Kari Lancaster
The International Journal on Drug Policy|August 13, 2013
Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985-2010Kari Lancaster, Alison Ritter
The International Journal on Drug Policy|July 17, 2019
Evidence-making hepatitis C cure: Towards a science that knows more carefullyTim Rhodes, Kari Lancaster
Social Science & Medicine (1982)|August 19, 2019
Evidence-making interventions in health: A conceptual framingTim Rhodes, Kari Lancaster
Sociology of Health & Illness|May 4, 2021
Excitable models: Projections, targets, and the making of futures without diseaseTim Rhodes, Kari Lancaster
The International Journal on Drug Policy|September 11, 2020
Towards an ontological politics of drug policy: Intervening through policy, evidence and methodKari Lancaster, Tim Rhodes
The International Journal on Drug Policy|May 22, 2016
Corrigendum to "Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985-2010" [Int. J. Drug Policy 25 (2014) 81-87]Kari Lancaster, Alison Ritter
Addiction (Abingdon, England)|March 13, 2018
Commentary on Chang et al. (2018): Assessing prescribing volume and patient risk-implementation considerationsSuzanne Nielsen, Kari Lancaster
Pageof 8